Covid-19: India gas maker shares jump amid shortage of life-saving oxygen

A Covid-19 patient waits to be allocated a bed at LNJP Hospital, amid shortage of beds and medical oxygen, as coronavirus cases surge in record numbers across the country, in New Delhi (Photo: PTI)
An acute shortage of medical oxygen in India, amid a deadly wave of coronavirus infections, has triggered a surge in stocks seen linked to industrial gases.

Supplies of medical oxygen, essential in many cases to treat seriously ill patients, have been depleted as hospitals around India have been overwhelmed by Covid-19 cases. The nation recorded 314,835 new infections on Thursday, the world’s biggest one-day jump, and taking its case-count to almost 16 million, the second-most globally.

Workers load refilled oxygen tanks into a vehicle at a refill station in Navi Mumbai, India, on Thursday, April 22, 2021. India saw a record one-day jump with more than 300,000 new coronavirus infections, marking a grim milestone for the country as a deadlier second wave showing no signs of abating.

 
Oxygen manufacturer Linde India Ltd. has gained more than 90% so far this year, while National Oxygen Ltd. has advanced 59%.

Even a company that doesn’t make or supply industrial gases, much less high-in-demand oxygen, has surged: While there’s no evidence that investors are buying Bombay Oxygen Investments Ltd. because of its name, shares in the firm with a market cap of $44 million have gained 132% from a Jan. 29 low.


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel